Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cd19 car-t cells (2 trials)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Lymphoma (Phase 1)
Lymphoma, B-Cell (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Recurrence (Phase 1)
Trials (2 total)
Trial APIs (1 total)